Clinical Trials Browser

Phase 1 × HER2-Positive Solid Tumors × 1 year × Clear all

NCT04501770 2025-07-20

A Study of M802 (HER2 and CD3) in HER2-Positive Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

HER2-Positive Solid Tumors